绿贝加速器

绿贝加速器

Male Apellis employee holding a horse saddle

Luis
Supply Chain at Apellis

绿贝加速器

Learn More
Folded page of a newspaper

绿贝加速器

绿贝加速器

Apellis Pharmaceuticals Reports Second Quarter 2024 Financial Results

绿贝加速器

Apellis Completes Enrollment in Two Phase 3 Studies of the Targeted C3 Therapy, Pegcetacoplan, in Patients with Geographic Atrophy (GA)

w加速器官网

Apellis Completes Enrollment in Phase 3 Study of Pegcetacoplan in Treatment-Naïve Patients with Paroxysmal Nocturnal Hemoglobinuria (PNH)

Newsroom
w加速器安卓

@ApellisPharma

A man with a baby in a baby carrier

绿贝加速器

FOR PATIENTS
Erlenmeyer flask, which represents the pre-clinical and clinical studies sponsored by Apellis Pharmaceuticals

绿贝加速器

for paroxysmal nocturnal hemoglobinuria, geographic atrophy,
C3 glomerulopathy, and cold agglutinin disease.

PIPELINE
3 arrows of different lengths, which represents the development status of pre-clinical and clinical studies for C3 complement targeted therapies

绿贝加速器

are targeted C3 therapies. These include potential medicines for a broad range of serious diseases driven by uncontrolled or excessive activation of the complement system.

CLINICAL TRIALS

绿贝加速器

so that Alexander, who is living with C3 glomerulopathy, can take his pug for a hike

We challenge conventional thinking and always question if there's a better way.

Join Us
w加速器app

Patricia
Quality Assurance at Apellis

hd2.0ne黑洞  gkd加速器最新官网  酷通v p n官网  海鸥加速器官网  彗星vp加速器加速器  AURORA极光官网  极光官方vnp网页版  破解版加速器加速器官网地址